When histiocyte are ischemic for a certain time and blood supply is suddenly restored, the pathological condition of rapidly aggravated tissue damage is called ischemia reperfusion injury, which is mainly caused by a large amount of Ca2+ influx and oxygen free radicals attacking ischemic histiocyte. Ischemia reperfusion injury can increase the incidence rate and mortality of some diseases, such as acute myocardial infarction, ischemic stroke, acute renal injury, intestinal obstruction, hyperkalemia and multiple organ failure, and it also brings great challenges to surgery such as organ transplantation. However, the current treatment methods for ischemia-reperfusion are still very limited. Fortunately, increasing evidence suggests that reasonable concentrations of hydrogen sulfide may play a powerful organ protective role in ischemia-reperfusion injury, mainly through mechanisms such as anti apoptotic, antioxidant, stress reduction, regulation of autophagy, and inhibition of inflammation. Therefore, hydrogen sulfide has profound clinical conversion prospects in the treatment of I/R injury. This article systematically summarizes the generation and physiological effects of endogenous hydrogen sulfide, as well as its protective mechanisms in different systems such as the heart, brain, kidney, liver, retina, and testes. In addition, the clinical transformation prospects and current challenges of hydrogen sulfide in ischemia-reperfusion injury were discussed.

Mpox (MPX), a zoonotic infection reported as early as 1970, is a double-stranded DNA virus, Mpox virus (MPXV), belonging to the genus Orthopoxvirus. MPX, a virus closely related to smallpox, was once considered a geographically restricted infection because it was predominantly endemic in West and Central Africa, except for the Democratic Republic of the Congo (DRC). However, in May 2022, a rare case of MPX was diagnosed in the UK. As of February 25, 2023, 86,127 confirmed cases and 97 deaths have been reported globally. It spreads through close contact with an infected person, infected animal, or an object which an infected person has touched. Although most people infected with MPXV may present with mild symptoms and will recover fully within a few weeks, people can have serious diseases and complications and may need to be hospitalized with it. Although smallpox vaccines and antiviral drugs are also effective against MPX, there is still no specific vaccine or drug for MPXV infection. Therefore, we need to take the right attitude and measures to stop the MPXV outbreak. In this review, we summarize the characteristics, mechanisms, immunology, and transmission of MPXV, as well as current vaccines, diagnostics, and treatments used for MPX, and provide clues for controlling MPX outbreaks and preventing such diseases.